Akebia Therapeutics, Inc.
US ˙ NasdaqCM ˙ US00972D1054

SecurityAKBA / Akebia Therapeutics, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership1,390,067 shares
Latest Disclosed Value $ 1,932,194
Citadel Advisors Llc ownership in AKBA / Akebia Therapeutics, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 1,390,067 shares of Akebia Therapeutics, Inc. (US:AKBA) valued at $1,932,193 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 4,665,537 shares of Akebia Therapeutics, Inc.. This represents a change in shares of -70.21% during the quarter. The current value of the position is $1,347,948 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (AKBA) in the form of stock options. The firm currently holds call options representing 178,200 of underlying shares valued at $247,698 USD and put options representing 158,100 of underlying shares valued at $219,759 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AKBA / Akebia Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AKEBIA THREAPEUTICS COM 00972D105 1,390,067 -3,275,470 -70.21 1,932 -74.28 0.0003
2026-02-17 2025-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 4,665,537 1,479,711 46.45 7,512 -13.64 0.0011
2025-11-14 2025-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 3,185,826 868,536 37.48 8,697 3.12 0.0013
2025-08-14 2025-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 2,317,290 -1,329,619 -36.46 8,435 20.45 0.0015
2025-05-15 2025-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 3,646,909 2,264,763 163.86 7,002 166.64 0.0013
2025-02-14 2024-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 1,382,146 1,382,146 2,626 0.0005
2024-11-14 2024-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 0 -214,669 -100.00 0 -100.00
2024-08-14 2024-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 214,669 131,435 157.91 219 43.42 0.0000
2024-05-15 2024-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 83,234 -105,360 -55.87 152 -34.76 0.0000
2024-02-14 2023-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 188,594 188,594 234 0.0000
2023-11-14 2023-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 0 -965 -100.00 0 0.0000
2023-08-14 2023-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 965 965 1 0.0000
2023-05-15 2023-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 0 -13,397 -100.00 0 -100.00
2023-02-14 2022-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 13,397 -287,777 -95.55 8 -92.63 0.0000
2022-11-14 2022-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 301,174 -156,129 -34.14 95 -41.36 0.0000
2022-08-15 2022-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 457,303 2,306 0.51 162 -50.31 0.0000
2022-05-16 2022-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 454,997 -110,900 -19.60 326 -74.51 0.0001
2022-02-14 2021-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 565,897 426,399 305.67 1,279 218.16 0.0003
2021-11-15 2021-09-30 13F AKEBIA THERAPEUTICS Cmn 00972D105 139,498 -65,222 -31.86 402 -48.20 0.0001
2021-08-16 2021-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 204,720 -167,395 -44.98 776 -38.41 0.0002
2021-05-21 2021-03-31 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 372,115 -608,146 -62.04 1,260 -54.10 0.0003
2021-05-17 2021-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 372,115 -608,146 1,260 0.0003
2021-02-16 2020-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 980,261 563,132 135.00 2,745 162.18 0.0007
2020-11-16 2020-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 417,129 368,387 755.79 1,047 58.16 0.0003
2020-08-14 2020-06-30 13F AKEBIA THERAPEUTICS Cmn 00972D105 48,742 -170,539 -77.77 662 -60.17 0.0002
2020-05-15 2020-03-31 13F AKEBIA THERAPEUTICS Cmn 00972D105 219,281 -688,939 -75.86 1,662 -71.05 0.0007
2020-02-14 2019-12-31 13F AKEBIA THERAPEUTICS Cmn 00972D105 908,220 537,470 144.97 5,740 295.04 0.0025
2019-11-14 2019-09-30 13F AKEBIA THERAPEUTICS Cmn 00972D105 370,750 268,218 261.59 1,453 192.35 0.0007
2019-08-14 2019-06-30 13F AKEBIA THERAPEUTICS Cmn 00972D105 102,532 70,086 216.01 497 87.55 0.0002
2019-05-15 2019-03-31 13F AKEBIA THERAPEUTICS Cmn 00972D105 32,446 -1,407,296 -97.75 265 -96.67 0.0001
2019-02-14 2018-12-31 13F AKEBIA THERAPEUTICS Cmn 00972D105 1,439,742 447,966 45.17 7,961 -9.10 0.0044
2018-11-13 2018-09-30 13F AKEBIA THERAPEUTICS Cmn 00972D105 991,776 371,440 59.88 8,758 41.44 0.0039
2018-08-14 2018-06-30 13F/A-1 AKEBIA THERAPEUTICS Cmn 00972D105 620,336 391,022 170.52 6,192 183.26 0.0031
2018-08-10 2018-06-30 13F AKEBIA THERAPEUTICS Cmn 00972D105 620,336 391,022 6,192
2018-05-14 2018-03-31 13F/A-1 AKEBIA THERAPEUTICS Cmn 00972D105 229,314 229,314 -63.03 2,186 -64.70 0.0012
2018-05-11 2018-03-31 13F AKEBIA THERAPEUTICS Cmn 00972D105 229,314 229,314 2,186
2017-11-09 2017-09-30 13F AKEBIA THERAPEUTICS Cmn 00972D105 0 -20,470 -100.00 0 -100.00
2017-08-11 2017-06-30 13F AKEBIA THERAPEUTICS Cmn 00972D105 20,470 -45,115 -68.79 294 -51.24 0.0002
2017-05-12 2017-03-31 13F AKEBIA THERAPEUTICS Cmn 00972D105 65,585 26,289 66.90 603 47.43 0.0006
2017-02-10 2016-12-31 13F AKEBIA THERAPEUTICS Cmn 00972D105 39,296 39,296 -40.08 409 -32.17 0.0004
2016-11-10 2016-09-30 13F AKEBIA THERAPEUTICS Cmn 00972D105 0 -25,818 -100.00 0 -100.00
2017-01-31 2016-06-30 13F/A-1 AKEBIA THERAPEUTICS Cmn 00972D105 25,818 4,699 22.25 193 1.58 0.0002
2016-08-12 2016-06-30 13F AKEBIA THERAPEUTICS Cmn 00972D105 25,818 193
2017-01-31 2016-03-31 13F/A-1 AKEBIA THERAPEUTICS Cmn 00972D105 21,119 21,119 -18.20 190 -1.55 0.0002
2016-05-13 2016-03-31 13F AKEBIA THERAPEUTICS Cmn 00972D105 21,119 190
2016-02-12 2015-12-31 13F AKEBIA THERAPEUTICS Cmn 00972D105 0 -63,802 -100.00 0 -100.00
2015-11-16 2015-09-30 13F AKEBIA THERAPEUTICS Cmn 00972D105 63,802 55,340 653.98 616 608.05 0.0006
2015-08-14 2015-06-30 13F AKEBIA THERAPEUTICS Cmn 00972D105 8,462 8,462 -86.74 87 -85.88 0.0001
2014-08-14 2014-06-30 13F AKEBIA THERAPEUTICS Cmn 00972D105 0 -18,448 -100.00 0 -100.00
2014-05-15 2014-03-31 13F AKEBIA THERAPEUTICS Cmn 00972D105 18,448 18,448 361 0.0005
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F AKEBIA THREAPEUTICS COM Call 178,200 21.47 248 4.66 n/a n/a n/a
2026-02-17 2025-12-31 13F AKEBIA THERAPEUTICS COM Call 146,700 38.79 236 -18.06 n/a n/a n/a
2025-11-14 2025-09-30 13F AKEBIA THERAPEUTICS COM Call 105,700 160.34 289 95.92 n/a n/a n/a
2025-08-14 2025-06-30 13F AKEBIA THERAPEUTICS COM Call 40,600 9.73 148 107.04 n/a n/a n/a
2025-05-15 2025-03-31 13F AKEBIA THERAPEUTICS COM Call 37,000 58.12 71 61.36 n/a n/a n/a
2025-02-14 2024-12-31 13F AKEBIA THERAPEUTICS COM Call 23,400 -81.65 44 -73.81 n/a n/a n/a
2024-11-14 2024-09-30 13F AKEBIA THERAPEUTICS COM Call 127,500 38.89 168 80.65 n/a n/a n/a
2024-08-14 2024-06-30 13F AKEBIA THERAPEUTICS COM Call 91,800 -32.05 94 -62.35 n/a n/a n/a
2024-05-15 2024-03-31 13F AKEBIA THERAPEUTICS COM Call 135,100 -3.15 247 43.60 n/a n/a n/a
2024-02-14 2023-12-31 13F AKEBIA THERAPEUTICS COM Call 139,500 8.73 173 17.81 n/a n/a n/a
2023-11-14 2023-09-30 13F AKEBIA THERAPEUTICS COM Call 128,300 17.28 146 46.00 n/a n/a n/a
2023-08-14 2023-06-30 13F AKEBIA THERAPEUTICS COM Call 109,400 46.26 100 143.90 n/a n/a n/a
2023-05-15 2023-03-31 13F AKEBIA THERAPEUTICS COM Call 74,800 -16.14 42 -19.61 n/a n/a n/a
2023-02-14 2022-12-31 13F AKEBIA THERAPEUTICS COM Call 89,200 18.77 51 112.50 n/a n/a n/a
2022-11-14 2022-09-30 13F AKEBIA THERAPEUTICS COM Call 75,100 -51.92 24 -56.36 n/a n/a n/a
2022-08-15 2022-06-30 13F AKEBIA THERAPEUTICS COM Call 156,200 -65.87 55 -83.28 n/a n/a n/a
2022-05-16 2022-03-31 13F AKEBIA THERAPEUTICS COM Call 457,700 780.19 329 178.81 n/a n/a n/a
2022-02-14 2021-12-31 13F AKEBIA THERAPEUTICS COM Call 52,000 -27.78 118 -43.00 n/a n/a n/a
2021-11-15 2021-09-30 13F AKEBIA THERAPEUTICS Cmn Call 72,000 -7.10 207 -29.59 n/a n/a n/a
2021-08-16 2021-06-30 13F AKEBIA THERAPEUTICS COM Call 77,500 -28.70 294 -20.11 n/a n/a n/a
2021-05-21 2021-03-31 13F/A AKEBIA THERAPEUTICS COM Call 108,700 -16.45 368 1.10 n/a n/a n/a
2021-05-17 2021-03-31 13F AKEBIA THERAPEUTICS COM Call 108,700 368 n/a n/a n/a
2021-02-16 2020-12-31 13F AKEBIA THERAPEUTICS COM Call 130,100 121.26 364 145.95 n/a n/a n/a
2020-11-16 2020-09-30 13F AKEBIA THERAPEUTICS COM Call 58,800 16.44 148 -78.43 n/a n/a n/a
2020-08-14 2020-06-30 13F AKEBIA THERAPEUTICS Cmn Call 50,500 112.18 686 281.11 n/a n/a n/a
2020-05-15 2020-03-31 13F AKEBIA THERAPEUTICS Cmn Call 23,800 -52.87 180 -73.76 n/a n/a n/a
2019-02-14 2018-12-31 13F AKEBIA THERAPEUTICS Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-13 2018-09-30 13F AKEBIA THERAPEUTICS Cmn Call 21,700 52.82 192 35.21 n/a n/a n/a
2018-08-14 2018-06-30 13F/A AKEBIA THERAPEUTICS Cmn Call 14,200 -4.05 142 0.71 n/a n/a n/a
2018-08-10 2018-06-30 13F AKEBIA THERAPEUTICS Cmn Call 14,200 142 n/a n/a n/a
2018-05-14 2018-03-31 13F/A AKEBIA THERAPEUTICS Cmn Call 14,800 -2.63 141 -37.61 n/a n/a n/a
2018-05-11 2018-03-31 13F AKEBIA THERAPEUTICS Cmn Call 14,800 141 n/a n/a n/a
2018-02-09 2017-12-31 13F AKEBIA THERAPEUTICS Cmn Call 15,200 -5.00 226 -28.25 n/a n/a n/a
2017-11-09 2017-09-30 13F AKEBIA THERAPEUTICS Cmn Call 16,000 5.26 315 39.38 n/a n/a n/a
2016-08-12 2016-06-30 13F AKEBIA THERAPEUTICS Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2016-03-31 13F/A AKEBIA THERAPEUTICS Cmn Call 16,300 147 n/a n/a n/a
2016-05-13 2016-03-31 13F AKEBIA THERAPEUTICS Cmn Call 16,300 147 n/a n/a n/a
2016-02-12 2015-12-31 13F AKEBIA THERAPEUTICS Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-11-16 2015-09-30 13F AKEBIA THERAPEUTICS Cmn Call 1,900 -80.00 18 -81.63 n/a n/a n/a
2015-08-14 2015-06-30 13F AKEBIA THERAPEUTICS Cmn Call 9,500 98 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F AKEBIA THREAPEUTICS COM Put 158,100 -25.32 220 -35.59 n/a n/a n/a
2026-02-17 2025-12-31 13F AKEBIA THERAPEUTICS COM Put 211,700 -8.04 341 -45.86 n/a n/a n/a
2025-11-14 2025-09-30 13F AKEBIA THERAPEUTICS COM Put 230,200 25.31 628 -5.99 n/a n/a n/a
2025-08-14 2025-06-30 13F AKEBIA THERAPEUTICS COM Put 183,700 23.54 669 134.39 n/a n/a n/a
2025-05-15 2025-03-31 13F AKEBIA THERAPEUTICS COM Put 148,700 65.59 286 67.65 n/a n/a n/a
2025-02-14 2024-12-31 13F AKEBIA THERAPEUTICS COM Put 89,800 26.12 171 82.80 n/a n/a n/a
2024-11-14 2024-09-30 13F AKEBIA THERAPEUTICS COM Put 71,200 -8.13 94 17.72 n/a n/a n/a
2024-08-14 2024-06-30 13F AKEBIA THERAPEUTICS COM Put 77,500 -62.40 79 -79.05 n/a n/a n/a
2024-05-15 2024-03-31 13F AKEBIA THERAPEUTICS COM Put 206,100 94.25 377 187.79 n/a n/a n/a
2024-02-14 2023-12-31 13F AKEBIA THERAPEUTICS COM Put 106,100 99.44 132 118.33 n/a n/a n/a
2023-11-14 2023-09-30 13F AKEBIA THERAPEUTICS COM Put 53,200 40.37 61 76.47 n/a n/a n/a
2023-08-14 2023-06-30 13F AKEBIA THERAPEUTICS COM Put 37,900 0.53 35 61.90 n/a n/a n/a
2023-05-15 2023-03-31 13F AKEBIA THERAPEUTICS COM Put 37,700 98.42 21 110.00 n/a n/a n/a
2023-02-14 2022-12-31 13F AKEBIA THERAPEUTICS COM Put 19,000 -41.54 11 0.00 n/a n/a n/a
2022-11-14 2022-09-30 13F AKEBIA THERAPEUTICS COM Put 32,500 24.52 10 11.11 n/a n/a n/a
2022-08-15 2022-06-30 13F AKEBIA THERAPEUTICS COM Put 26,100 -83.56 9 -92.11 n/a n/a n/a
2022-05-16 2022-03-31 13F AKEBIA THERAPEUTICS COM Put 158,800 100.76 114 -36.31 n/a n/a n/a
2022-02-14 2021-12-31 13F AKEBIA THERAPEUTICS COM Put 79,100 -36.77 179 -50.28 n/a n/a n/a
2021-11-15 2021-09-30 13F AKEBIA THERAPEUTICS Cmn Put 125,100 -41.18 360 -55.33 n/a n/a n/a
2021-08-16 2021-06-30 13F AKEBIA THERAPEUTICS COM Put 212,700 61.26 806 80.72 n/a n/a n/a
2021-05-21 2021-03-31 13F/A AKEBIA THERAPEUTICS COM Put 131,900 12.93 446 36.39 n/a n/a n/a
2021-05-17 2021-03-31 13F AKEBIA THERAPEUTICS COM Put 131,900 446 n/a n/a n/a
2021-02-16 2020-12-31 13F AKEBIA THERAPEUTICS COM Put 116,800 -29.47 327 -21.39 n/a n/a n/a
2020-11-16 2020-09-30 13F AKEBIA THERAPEUTICS COM Put 165,600 1,074.47 416 117.80 n/a n/a n/a
2020-08-14 2020-06-30 13F AKEBIA THERAPEUTICS Cmn Put 14,100 -52.04 191 -14.35 n/a n/a n/a
2020-05-15 2020-03-31 13F AKEBIA THERAPEUTICS Cmn Put 29,400 -12.50 223 5.19 n/a n/a n/a
2020-02-14 2019-12-31 13F AKEBIA THERAPEUTICS Cmn Put 33,600 14.29 212 -4.93 n/a n/a n/a
2019-02-14 2018-12-31 13F AKEBIA THERAPEUTICS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-13 2018-09-30 13F AKEBIA THERAPEUTICS Cmn Put 17,000 -20.56 150 -29.91 n/a n/a n/a
2018-08-14 2018-06-30 13F/A AKEBIA THERAPEUTICS Cmn Put 21,400 25.88 214 42.67 n/a n/a n/a
2018-08-10 2018-06-30 13F AKEBIA THERAPEUTICS Cmn Put 21,400 214 n/a n/a n/a
2016-11-10 2016-09-30 13F AKEBIA THERAPEUTICS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2016-06-30 13F/A AKEBIA THERAPEUTICS Cmn Put 17,800 50.85 133 25.47 n/a n/a n/a
2016-08-12 2016-06-30 13F AKEBIA THERAPEUTICS Cmn Put 17,800 133 n/a n/a n/a
2017-01-31 2016-03-31 13F/A AKEBIA THERAPEUTICS Cmn Put 11,800 -33.71 106 -20.30 n/a n/a n/a
2016-05-13 2016-03-31 13F AKEBIA THERAPEUTICS Cmn Put 11,800 106 n/a n/a n/a
2016-02-12 2015-12-31 13F AKEBIA THERAPEUTICS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-11-16 2015-09-30 13F AKEBIA THERAPEUTICS Cmn Put 5,500 161.90 53 140.91 n/a n/a n/a
2015-08-14 2015-06-30 13F AKEBIA THERAPEUTICS Cmn Put 2,100 22 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.